Polatuzumab Vedotin in a Patient with Refractory Burkitt Lymphoma, a Case Report

Alanzi M, Abu-Tineh M, Szabados L, Sharaf Eldean M, Alatasi S, Taha RY, Elkourashy SA

OncoTargets and Therapy 2023, 16:133-139

Published Date: 21 February 2023